When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - VistaGen's AV-101 flunks MDD study; shares down 67%
VistaGen Therapeutics Inc.
Thinly traded nano cap VistaGen Therapeutics (VTGN-67%) craters on more than a 9x surge in volume after AV-101 failed to separate from placebo in a Phase 2 clinical trial, ELEVATE, evaluating the candidate for the adjunctive treatment of major depressive disorder.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news, Stocks on the move,